We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$88.2M
1-Year Est. Return
25.13%
This Fund
S&P 500
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+25.13%
3 Year Est. Return
+30.54%
5 Year Est. Return
+27.6%
10 Year Est. Return
+989.99%
AUM
$89.1M
AUM Growth
+$757K
(+0.86%)
Cap. Flow
+$1.04M
Cap. Flow
% of AUM
1.16%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
70
New
6
Increased
13
Reduced
22
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNCR
Synchronoss Technologies
SNCR
|
+$3.91M |
| 2 |
Morgan Stanley
MS
|
+$1.15M |
| 3 |
Marchex
MCHX
|
+$741K |
| 4 |
VRTU
Virtusa Corporation
VRTU
|
+$663K |
| 5 |
Weyerhaeuser
WY
|
+$641K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iovance Biotherapeutics
IOVA
|
+$1.54M |
| 2 |
Qualcomm
QCOM
|
+$975K |
| 3 |
Cognizant
CTSH
|
+$872K |
| 4 |
Calix
CALX
|
+$848K |
| 5 |
PCL
PLUM CREEK TIMBER CO (REIT)
PCL
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.78% |
| 2 | Financials | 15.02% |
| 3 | Healthcare | 13.89% |
| 4 | Communication Services | 10.24% |
| 5 | Energy | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Akebia Therapeutics
AKBA
$327M
| $1.22M | 1.36% |
135,000
+25,000
| +23% | +$203K |
|
|
EXAR
27
DELISTED
Exar Corporation
EXAR
| $1.15M | 1.29% |
200,000
| – | – |
|
|
LJPC
28
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.13M | 1.27% |
54,000
+3,600
| +7% | +$64.2K |
|
|
29
Morgan Stanley
MS
$337B
| $1.13M | 1.26% |
+45,000
| New | +$1.15M |
|
30
Amgen
AMGN
$203B
| $1.12M | 1.26% |
7,500
+1,500
| +25% | +$223K |
|
|
SHOR
31
DELISTED
ShoreTel, Inc.
SHOR
| $1.12M | 1.25% |
150,000
-20,000
| -12% | -$153K |
|
32
Gilead Sciences
GILD
$161B
| $1.1M | 1.24% |
12,000
| – | – |
|
|
BBBY
33
DELISTED
Bed Bath & Beyond Inc
BBBY
| $993K | 1.11% |
20,000
| – | – |
|
|
LKM
34
DELISTED
Link Motion Inc.
LKM
| $916K | 1.03% |
200,000
| – | – |
|
35
Digital Turbine
APPS
$1.02B
| $904K | 1.01% |
760,000
-40,000
| -5% | -$47.2K |
|
36
Check Point Software Technologies
CHKP
$13.3B
| $875K | 0.98% |
10,000
| – | – |
|
37
Philip Morris
PM
$301B
| $785K | 0.88% |
8,000
-400
| -5% | -$36.7K |
|
38
Johnson & Johnson
JNJ
$635B
| $757K | 0.85% |
7,000
| – | – |
|
39
Verizon
VZ
$194B
| $757K | 0.85% |
14,000
-1,000
| -7% | -$50K |
|
40
AT&T
T
$165B
| $744K | 0.83% |
25,156
-2,648
| -10% | -$73.3K |
|
|
41
Weyerhaeuser
WY
$17.3B
| $744K | 0.83% |
+24,000
| New | +$641K |
|
42
PepsiCo
PEP
$186B
| $717K | 0.8% |
7,000
| – | – |
|
43
GE Aerospace
GE
$367B
| $699K | 0.78% |
4,591
-626
| -12% | -$88.4K |
|
44
Procter & Gamble
PG
$343B
| $658K | 0.74% |
8,000
| – | – |
|
45
Coca-Cola
KO
$354B
| $649K | 0.73% |
14,000
-1,000
| -7% | -$43.5K |
|
|
DD
46
DELISTED
Du Pont De Nemours E I
DD
| $633K | 0.71% |
10,000
| – | – |
|
|
47
Cognizant
CTSH
$21.5B
| $627K | 0.7% |
10,000
-15,000
| -60% | -$872K |
|
48
Altria Group
MO
$122B
| $627K | 0.7% |
10,000
-2,000
| -17% | -$121K |
|
49
Chevron
CVX
$388B
| $620K | 0.7% |
6,500
| – | – |
|
50
PayPal
PYPL
$49.5B
| $618K | 0.69% |
16,000
| – | – |
|
Similar funds
MPEM
RFL
GBA
BLC
PBCM
PM
BCP
CVM
P.A.W. Capital's Q1 2016 Portfolio in Review
As of Q1 2016, P.A.W. Capital held 70 positions worth $89.1M, up 0.86% from $88.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
P.A.W. Capital's Q1 2016 filing shows 6 new, 13 increased, 22 reduced and 5 closed positions. Its largest new stake was Morgan Stanley: 45,000 shares worth $1.13M. The largest sale was Iovance Biotherapeutics, an estimated $1.54M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
- P.A.W. Capital's largest Q1 2016 buy was Morgan Stanley: 45,000 shares worth $1.13M.
- P.A.W. Capital added most to Synchronoss Technologies in Q1 2016, an estimated $3.91M increase.
- P.A.W. Capital's biggest Q1 2016 reduction was Qualcomm, cutting an estimated $975K.
- P.A.W. Capital fully exited Iovance Biotherapeutics in Q1 2016, selling an estimated $1.54M.
- P.A.W. Capital's ten largest holdings make up 40% of its $89.1M portfolio in Q1 2016.
- P.A.W. Capital opened 6 new positions and closed 5 in Q1 2016.
- P.A.W. Capital's portfolio value rose 0.86% quarter-over-quarter to $89.1M.
Based on P.A.W. Capital's 13F filing for Q1 2016, filed 5 May 2016.